文献速递脑血管病

骨关节炎与大血管急性缺血性卒中取栓治疗使用及结局的关联

Associations of Osteoarthritis With Thrombectomy Utilization and Outcomes for Large Vessel Acute Ischemic Stroke.
PubMed 文献 · Stroke · 2022-12-21

经倾向评分匹配和多变量logistic回归校正混杂因素后,骨关节炎患者接受血管内取栓的几率显著降低22.6%(OR 0.77,95%CI 0.70-0.86),但取栓后出院回家和院内死亡结局与无骨关节炎者无显著差异。作者认为这些结果需进一步研究,并提示应批判性审视当前取栓患者选择实践,尤其是因骨关节炎等肌肉骨骼疾病导致基线残疾的患者。

要点

  • 大血管缺血性卒中合并骨关节炎者接受血管内取栓的几率降低22.6%(OR 0.77,95%CI 0.70-0.86)。
  • 匹配32项临床变量后,骨关节炎患者取栓率14.4%,非骨关节炎患者17.3%(P<0.001)。
  • 取栓后骨关节炎与出院回家无显著关联(OR 0.99,95%CI 0.81-1.21),与院内死亡呈边缘性关联(OR 0.74,95%CI 0.54-1.01,P=0.054)。

核心结论

  • 大血管缺血性卒中合并骨关节炎患者接受血管内取栓治疗的可能性显著更低,但取栓后结局相似。
  • 这些结果需进一步研究,并提示应批判性审视当前卒中取栓患者选择实践,尤其是因骨关节炎等肌肉骨骼疾病导致基线残疾的患者。

研究设计与样本

  • 2016至2019年美国全国住院患者样本库的大规模横断面研究,纳入前循环大血管缺血性卒中成人患者。
  • 主要结局为血管内取栓治疗率,次要结局包括出院回家率和院内死亡率。

主要发现

  • 倾向评分匹配后,骨关节炎患者接受血管内取栓的比例为14.4%,非骨关节炎患者为17.3%(P<0.001),骨关节炎患者接受取栓的可能性低17.3%。
  • 多变量logistic回归显示,骨关节炎与接受血管内取栓的几率降低22.6%相关(OR 0.77,95%CI 0.70-0.86;P<0.001),其效应量大于本研究中除痴呆和非卒中神经系统疾病外的任何医学合并症。
  • 在接受血管内取栓治疗的患者中,多变量logistic回归显示骨关节炎与出院回家的几率无显著关联(OR 0.99,95%CI 0.81-1.21;P=0.93)。
  • 骨关节炎与院内死亡几率呈边缘性关联(OR 0.74,95%CI 0.54-1.01;P=0.054)。

临床怎么用

  • 作者认为这些结果需进一步研究,并提示应批判性审视当前卒中血管内取栓治疗的患者选择实践,尤其是因骨关节炎等肌肉骨骼疾病导致基线残疾的患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Osteoarthritis and other musculoskeletal disorders are the leading causes of disability in the United States. While osteoarthritis is not a direct risk factor for stroke, osteoarthritis may impact patient selection for endovascular thrombectomy (EVT) due to prestroke disability. This study investigates associations of osteoarthritis with EVT utilization and outcomes. METHODS: This was a large-scale cross-sectional study of the 2016 to 2019 National Inpatient Sample database. Adult patients with anterior large vessel ischemic strokes were identified. Patient demographics, stroke risk factors, stroke etiology, presence of osteoarthritis, medical comorbidities, EVT, intravenous thrombolysis treatments, and discharge destinations were recorded. Primary outcome was the rate of EVT treatment. Secondary outcomes include rates of discharge to home and in-hospital mortality. Propensity score matching and multivariable logistic regression models were used to account for possible confounders. RESULTS: Two hundred fifty-two thousand five hundred five patients were identified, of whom 8.5% (21 500 patients) had osteoarthritis. After propensity score matching for 32 clinical variables, osteoarthritis patients were found to be 17.3% less likely to receive EVT than non-osteoarthritis patients (14.4% versus 17.3%, respectively; P<0.001). In multivariable logistic regression analysis, osteoarthritis was associated with 22.6% lower odds of receiving EVT (OR, 0.77 [95% CI, 0.70-0.86]; P<0.001), an effect size larger than any medical comorbidity captured in this study other than dementia and nonstroke neurological disease. Among those treated with EVT, multivariable logistic regression models showed that osteoarthritis was not associated with different odds of being discharged home (OR, 0.99 [95% CI, 0.81-1.21]; P=0.93); however, osteoarthritis was marginally associated with lower odds of in-hospital mortality (OR, 0.74 [95% CI, 0.54-1.01]; P=0.054). CONCLUSIONS: Large vessel ischemic stroke patients with osteoarthritis were significantly less likely to receive EVT therapy despite similar post-EVT outcomes. These results warrant further investigation and prompt a critical review of current patient selection practices for stroke EVT therapy, specifically for patients with baseline disability due to musculoskeletal conditions such as osteoarthritis.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Chen H, Khunte M, Colasurdo M, et al. Associations of Osteoarthritis With Thrombectomy Utilization and Outcomes for Large Vessel Acute Ischemic Stroke. Stroke. 2022. PMID: 36541211. doi:10.1161/STROKEAHA.122.041749

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。